Related Experiment Video

Updated: May 29, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients

Kerstin Wustmann1, Marco Klaey, Annika Burow

  • 1Cardiology, Swiss Cardiovascular Center Bern, University Hospital Bern, Switzerland.

Cardiovascular Therapeutics
|September 3, 2011
PubMed

Insights

Rosuvastatin and B-group vitamins improve endothelial function in cardiovascular patients. Combination therapy showed an additive effect, suggesting distinct mechanisms of action for treating endothelial dysfunction.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Nutritional Science

Background:

  • Endothelial dysfunction is a key indicator in atherosclerosis development and progression.
  • Statin therapy, like rosuvastatin, benefits cardiovascular patients by lowering LDL-cholesterol and through pleiotropic effects.
  • B-group vitamin supplementation enhances endothelial function by mitigating homocysteine-induced oxidative stress.

Purpose of the Study:

  • To investigate the individual and combined effects of rosuvastatin and B-group vitamins on endothelial function.
  • To assess the impact on flow-mediated vasodilation (FMD) in high-risk cardiovascular patients.

Main Methods:

  • A randomized, double-blind study involving 36 cardiovascular patients.
  • Patients were assigned to rosuvastatin (10 mg) or B-group vitamin supplementation (folic acid, B12, B6) for 6 weeks.
  • Following the initial 6 weeks, all patients received combination therapy for an additional 6 weeks, with FMD assessed at baseline, 6, and 12 weeks.

Main Results:

  • Both rosuvastatin and vitamin supplementation significantly improved FMD after 6 weeks.
  • Rosuvastatin's improvement was linked to reduced plasma lipids, while vitamin supplementation correlated with decreased homocysteine levels.
  • Combined therapy over 12 weeks further enhanced FMD, normalizing it in a majority of patients.

Conclusions:

  • Both rosuvastatin and B-group vitamin supplementation are effective in improving endothelial function in high-risk cardiovascular patients.
  • The combination therapy demonstrated an additive effect on endothelial function.
  • The findings suggest that rosuvastatin and B-group vitamins act through different mechanisms to improve endothelial health.
Abstract

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...